Please login to the form below

Not currently logged in
Email:
Password:

disease progression

This page shows the latest disease progression news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash

Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash

An interim analysis of data from the phase 3 IMPower131 study in women with metastatic triple negative breast cancer has shown the combination significantly reduced the risk of disease worsening or ... Impassion130 is the first positive phase III

Latest news

More from news
Approximately 1 fully matching, plus 230 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    to 12-week course. And Spinraza from Biogen, the first ever disease-modifying treatment for spinal muscular atrophy (SMA), which increases the body’s ability to produce SMN protein critical to. ... Curative therapies have the potential to offset

  • A quest for innovative solutions A quest for innovative solutions

    disease progression. ... It is important that patients can see the value in tracking their disease.

  • Pfizer and IBM's tech-enabled 'Parkinson’s house' Pfizer and IBM's tech-enabled 'Parkinson’s house'

    But this elegant home, surrounded by manicured lawns, is wired to beat the scourge of Parkinson’s disease. ... To show the stopping of disease progression can take a couple of years and that is a long time to conduct a clinical trial, so we hope we can

  • Accelerating innovation Accelerating innovation

    The new trial of previously untreated patients with advanced RCC showed a 52% reduction in the rate of disease progression or death compared to Sutent, with Cabometyx showing median progression-free

  • Reading human behaviour to create a medical future Reading human behaviour to create a medical future

    to describe disease onset and progression in whole new ways, as well as therapeutic impact, and to develop digital biomarkers to deliver more proactive care to patients based on their everyday ... products but others, patients feel empowered and

More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.

Latest appointments

  • PatientsLikeMe names Jason Johnson as head of R&D PatientsLikeMe names Jason Johnson as head of R&D

    Johnson will lead the company's research, data science and informatics teams, which focus on analysing and merging patient-reported data and other data types to develop models of disease progression ... and generate new insights about disease, treatments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Ben Hwang discusses innovative diagnostic real-time monitoring data-sensors

    us about how continuous data sensors could transform the way we monitor patients’ disease progression and treatment efficacy. ... Profusa have recently received approval for their first product to measure blood stats in respiratory disease.

  • emotive shortlisted for four awards at the PM Digital Awards 2016

    For the first time, cardiologists can explore in detail the inside of different patients’ beating hearts, experience the symptoms and comorbidities of aortic stenosis, and change the disease’ s severity to ... Innovation. The second is

  • Alzheimer’s disease: reviewing the immediate treatment horizon

    so.Unfortunately, the complexity of the disease has meant that many recent AD trials have been unsuccessful. ... only capable of slowing the progression of disease symptoms.

  • Immunotherapy in oncology

    These three states align with the clinical observations of response, stable disease and progression of disease. ... With immunotherapies, even patients with stable disease have experienced significant survival benefit while responders have far exceeded

  • Generating patient insights using co-design

    patient's current condition, their disease type, time since diagnosis, and stage of disease at diagnosis. ... The patient's condition will change according to the effectiveness of the treatment and the progression of the disease.

More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics